Company / CapEx per Share
Repligen CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$415.82
FY2025
5-year range
$415.82 / $1476.53
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#1 of 192
Health Care
What the data says
Among 192 Health Care companies, Repligen is in the top 1% for capex per share. CapEx per Share has declined for 3 consecutive years, from $1476.53 in FY2022 to $415.82 in FY2025.
Based on SEC 10-K filings.
415.82 in FY2025 with a 5-year CAGR of -0.0%. Ranks 1st among 192 companies in Health Care.
Declined from $642.50 to $415.82 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -34.5%
- 5-Year CAGR
- -0.0%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 192This company $415.82 Sector average $2.46
▼
+16782.1% above sector average
Key checks
Key Insights
- Repligen's capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 9.4% year-over-year.
- Ranks #1 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $415.82 | -9.4% |
| FY2024 | $459.03 | -28.6% |
| FY2023 | $642.50 | -56.5% |
| FY2022 | $1476.53 | +26.0% |
| FY2021 | $1171.57 | +181.2% |
| FY2020 | $416.67 | +110700.4% |
| FY2019 | $0.38 | +60.8% |
| FY2018 | $0.23 | +45.1% |
| FY2017 | $0.16 | +22.8% |
| FY2016 | $0.13 | -7.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026